Simple Summary Thymic carcinoma is a rare cancer, and its biology remains largely
unknown. Although complete surgical resection is a standard treatment for thymic …

Thymic carcinoma is a rare entity and can be distinguished from benign thymomas by their
aggressive nature and poor prognosis. The National Comprehensive Cancer Network …

Thymic malignancies are rare epithelial tumors that may be aggressive and difficult to treat.
Thymomas are usually localized to the anterior mediastinum and are frequently eligible for …

Thymic malignancies represent a wide range of clinical, histological and molecular entities,
with probably considerable heterogeneity even among tumors of the same histotype …

Introduction Thymic carcinoma (TC) is an exceptionally rare form of tumor that differs from
thymoma by virtue of its very poor prognosis. The difficulties associated with conducting …

Purpose A key challenge in the treatment of thymoma and thymic carcinoma (TC) is in
improving our understanding of the molecular biology of these relatively rare tumors. In …

Importance of the field: Since first reported just over 30 years ago, some progress has been
made in our understanding of thymic cancer–an extremely rare cancer–and how to treat it …

Opinion statement Thymomas and thymic carcinomas are rare diseases of the anterior
mediastinum. Although some thymomas are quite indolent and able to be resected in a …

Opinion statement Although thymic epithelial tumors are rare, they are relatively common
among neoplasms of the anterior superior mediastinum. They usually exhibit indolent …

Purpose Thymic malignancies, comprising thymoma and thymic carcinoma, are rare.
Consequently, optimal chemotherapy for advanced thymic malignancies remains …